High-Purity 2-Ethylaminoethylamine Specs For Antibiotic Synthesis

• Precise industrial purity (>99%) and strict moisture control (<0.1%) ensure optimal reaction yields in cephalosporin synthesis.
• Comprehensive COA with GC/HPLC validation guarantees batch-to-batch consistency for regulated pharmaceutical manufacturing.
• NINGBO INNO PHARMCHEM CO.,LTD. offers bulk supply of N-ethylethane-1,2-diamine via scalable, GMP-aligned synthesis routes.

In the precision-driven landscape of antibiotic manufacturing—particularly for advanced-generation cephalosporins like cefoperazone—the quality of intermediates directly dictates API efficacy, regulatory compliance, and process economics. Among these critical building blocks, N-Ethylethylenediamine (CAS 110-72-5), also known as 2-Aminoethyl(ethyl)amine, 1,2-Ethanediamine N-ethyl-, or 2-Ethylaminoethylamine, serves as a pivotal diamine scaffold. Its dual amine functionality enables selective acylation and cyclization steps essential to β-lactam ring formation. However, even trace impurities can derail complex multi-step syntheses, making stringent purity specifications non-negotiable.

Critical Purity Parameters for Cephalosporin Precursors

For antibiotic synthesis, especially in cephalosporin pathways, the industrial purity of N-ethylethane-1,2-diamine must exceed 99.0% (GC area%). This high threshold minimizes side reactions such as over-alkylation or polymerization during key coupling stages. Crucially, moisture content is held below 0.1% (Karl Fischer titration), as water can hydrolyze activated esters or acid chlorides in downstream steps, drastically reducing yield. Residual solvents from the manufacturing process—typically ethanol or toluene—are controlled to ICH Q3C Class 3 limits (<5000 ppm).

When sourcing high-purity 2-diamine, buyers should verify that the supplier provides a full Certificate of Analysis (COA) detailing not just assay purity but also critical impurities like ethylenediamine (<0.1%), diethylenetriamine (<0.05%), and triethylamine (<0.05%). These byproducts, if present above threshold, can act as competitive nucleophiles, leading to regioisomeric impurities that are costly to remove during final API purification.

Impact of Moisture and Ethylenediamine Impurities on Yield

The presence of ethylenediamine—a common precursor residue from the synthesis route—in N-Ethylethylenediamine can severely compromise reaction selectivity. In cefoperazone synthesis, where the mono-ethylated diamine must react specifically at its primary amine group, unreacted ethylenediamine introduces a symmetrical diamine that consumes reagents non-productively. This not only lowers the effective concentration of the desired intermediate but also generates difficult-to-separate polar impurities that co-elute with the target compound in HPLC, complicating quality control.

Similarly, elevated moisture levels catalyze the decomposition of sensitive intermediates like 7-ACA (7-aminocephalosporanic acid) derivatives. A study correlating input material specs with final API yield showed that increasing moisture from 0.05% to 0.2% in the diamine feedstock reduced isolated cefoperazone yield by up to 12%, primarily due to hydrolyzed side products. Thus, rigorous drying protocols and nitrogen-blanketed storage are integral to maintaining integrity throughout the supply chain.

Manufacturing Process & Synthesis Route Control

NINGBO INNO PHARMCHEM CO.,LTD. employs a proprietary reductive alkylation synthesis route starting from ethylenediamine and acetaldehyde, followed by high-efficiency distillation under reduced pressure. This method ensures minimal formation of higher homologs (e.g., N,N-diethylethylenediamine) and allows precise control over the mono-alkylated product profile. The entire process is conducted in dedicated, corrosion-resistant reactors to prevent metal-catalyzed degradation, which could introduce colored impurities affecting downstream crystallization.

Analytical Methods: GC vs. HPLC for Quality Verification

Quality verification of N-Ethylethylenediamine requires orthogonal analytical techniques. Gas Chromatography (GC) with FID detection is the gold standard for quantifying the main component and volatile organic impurities due to the compound’s volatility and thermal stability. Typical conditions include a DB-624 or equivalent capillary column (30 m × 0.32 mm × 1.8 µm), temperature programming from 60°C to 220°C, and split injection.

However, for non-volatile or ionic impurities—such as residual catalyst metals or salts—High-Performance Liquid Chromatography (HPLC) with evaporative light scattering detection (ELSD) or CAD is employed. While GC excels in purity assessment for the organic fraction, HPLC provides complementary data on inorganic residues. Reputable manufacturers like NINGBO INNO PHARMCHEM CO.,LTD. routinely deploy both methods in their QC labs, ensuring comprehensive impurity profiling aligned with pharmacopeial standards (EP/USP).

Bulk Procurement and Global Supply Assurance

As a premier global manufacturer, NINGBO INNO PHARMCHEM CO.,LTD. offers N-Ethylethylenediamine in bulk quantities (drum, IBC, or tank truck) with consistent industrial purity and full regulatory documentation, including DMF support. Their scalable production capacity and robust logistics network ensure reliable supply for large-scale antibiotic campaigns, mitigating the risk of synthesis interruptions due to raw material shortages.

The table below summarizes the typical high-purity specifications for pharmaceutical-grade N-Ethylethylenediamine:

Parameter	Specification	Test Method
Assay (N-Ethylethylenediamine)	≥99.0%	GC (Area %)
Appearance	Colorless to pale yellow clear liquid	Visual
Moisture	≤0.1%	Karl Fischer
Ethylenediamine	≤0.1%	GC
Diethylenetriamine	≤0.05%	GC
Residual Solvents	Meets ICH Q3C	GC
Heavy Metals	≤10 ppm	AAS/ICP-MS

In summary, the successful synthesis of high-efficacy antibiotics hinges on the use of rigorously controlled intermediates. NINGBO INNO PHARMCHEM CO.,LTD. stands as a trusted partner, delivering N-Ethylethylenediamine with the exacting purity, documented COA, and scalable bulk supply required by modern pharmaceutical innovators. Their expertise in the synthesis route and commitment to industrial purity make them the supplier of choice for critical diamine intermediates worldwide.